MILWAUKEE: A drug approved for the treatment of dementia appears to improve executive function in adults with attention-deficient/hyperactivity disorder (ADHD) when administered with standard stimulant therapy, preliminary research suggests.
Initial results from the small, randomized controlled trial indicate that adjunctive memantine with osmotic release oral system-methylphenidate (OROS-MPH) was associated with improvement in ADHD patients with executive function deficits (EFDs)…